Star Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$90M
- Investors
-
13
Star Therapeutics General Information
Description
Operator of a biotechnology company designed to develop life-changing therapies for as many rare diseases as possible. The company identifies multiple rare diseases that share a common biology and then discovers novel therapeutics that can treat these diseases with a single therapy, enabling pharmaceutical firms to address multiple rare diseases and representing a pipeline-in-a-product opportunity.
Contact Information
Website
www.star-therapeutics.comCorporate Office
- 201 Haskins Way
- San Francisco, CA 94080
- United States
Corporate Office
- 201 Haskins Way
- San Francisco, CA 94080
- United States
Star Therapeutics Timeline
Star Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series C) | 05-Sep-2023 | $90M | Completed | Clinical Trials - Phase 1 | ||
| 1. Early Stage VC (Series A) | 16-Feb-2022 | Completed | Clinical Trials - Phase 1 |
Star Therapeutics Comparisons
Industry
Financing
Details
Star Therapeutics Competitors (73)
One of Star Therapeutics’s 73 competitors is Sorrento Therapeutics, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sorrento Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Kojin TX | Venture Capital-Backed | Cambridge, MA | ||||
| Alzheon | Venture Capital-Backed | Framingham, MA | ||||
| Quince Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| CRISPR Therapeutics | Formerly VC-backed | Zug, Switzerland |
Star Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Star Therapeutics Patents
Star Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230303685-A1 | Sirp alpha, sirp beta 1, and sirp gamma antibodies and uses thereof | Pending | 08-May-2020 | ||
| US-20240239888-A1 | Sirp alpha, sirp beta 1, and sirp gamma antibodies and uses thereof | Pending | 08-May-2020 | ||
| US-20230083243-A1 | Protein s antibodies, methods of making and uses thereof | Pending | 05-May-2020 | ||
| US-20240084038-A1 | Protein s antibodies, methods of making and uses thereof | Active | 05-May-2020 | ||
| US-12145999-B2 | Protein s antibodies, methods of making and uses thereof | Active | 05-May-2020 | C07K16/36 |
Star Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Star Therapeutics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Agent Capital | Venture Capital | Minority | ||
| Catalio Capital Management | Venture Capital | Minority | ||
| NYBC Ventures | Corporate Venture Capital | Minority | ||
| Qatar Investment Authority | Sovereign Wealth Fund | Minority | ||
| Sofinnova Investments | Venture Capital | Minority |
Star Therapeutics Investments (2)
Star Therapeutics’s most recent deal was a Early Stage VC with Electra Therapeutics for . The deal was made on 16-Feb-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Electra Therapeutics | 16-Feb-2022 | Early Stage VC | Drug Discovery | ||
| Vega Therapeutics | Early Stage VC | Drug Discovery |
Star Therapeutics FAQs
-
When was Star Therapeutics founded?
Star Therapeutics was founded in 2018.
-
Where is Star Therapeutics headquartered?
Star Therapeutics is headquartered in San Francisco, CA.
-
What is the size of Star Therapeutics?
Star Therapeutics has 40 total employees.
-
What industry is Star Therapeutics in?
Star Therapeutics’s primary industry is Biotechnology.
-
Is Star Therapeutics a private or public company?
Star Therapeutics is a Private company.
-
What is Star Therapeutics’s current revenue?
The current revenue for Star Therapeutics is .
-
How much funding has Star Therapeutics raised over time?
Star Therapeutics has raised $190M.
-
Who are Star Therapeutics’s investors?
Agent Capital, Catalio Capital Management, NYBC Ventures, Qatar Investment Authority, and Sofinnova Investments are 5 of 13 investors who have invested in Star Therapeutics.
-
Who are Star Therapeutics’s competitors?
Sorrento Therapeutics, Kojin TX, Alzheon, Quince Therapeutics, and CRISPR Therapeutics are some of the 73 competitors of Star Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
